“`html
West Coast Health Alliance Urges Continued Newborn Hepatitis B Vaccination Amid CDC Advisory Committee Shift
A coalition of leading health organizations is reaffirming the importance of routine hepatitis B vaccination for all newborns, following a recent vote by the CDC’s Advisory Committee on Immunization Practices (ACIP) to alter decades-long recommendations.
The West Coast Health Alliance (WCHA), alongside national medical organizations like the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the Infectious Diseases Society of America, strongly supports continuing the current practice of administering the first dose of the hepatitis B vaccine within 24 hours of birth for newborns weighing at least 2,000 grams (4 pounds, 7 ounces), with completion of the vaccine series following. This stance directly challenges the ACIP’s recent decision to end the global proposal for infant hepatitis B vaccination – a strategy credited with reducing pediatric hepatitis B infections in the United States by 99 percent.
The ACIP also voted to suggest parents consult their healthcare provider regarding blood tests after each vaccine dose. However, a statement released by the WCHA asserts that “there was no credible evidence presented to support either of these changes.” According to the alliance, delaying the birth dose and relying on blood tests will likely result in increased rates of preventable liver disease and cancer, without any demonstrated safety benefits.
A review conducted by the Vaccine Integrity Project further supports the WCHA’s position, finding the vaccine to be safe regardless of timing and identifying no advantages to delaying the initial dose. “Delaying the first dose increases the risk of infection and jeopardizes completion of the full vaccine series,which is required for long-lasting protection,” the WCHA explained. The institution emphasized that many individuals with chronic hepatitis B are unaware of their infection, and infants are particularly vulnerable to transmission from household contacts. The birth dose, therefore, serves as a crucial preventative measure.
Hepatitis B is a highly contagious virus that poses a important threat to liver health, possibly leading to chronic disease, liver cancer, liver failure, and even death. The virus can survive for up to seven days on surfaces and spreads easily, even without visible blood or bodily fluids. Prior to the implementation of universal infant vaccination in 1991, thousands of children were infected annually. Infants and young children are especially susceptible,with up to 90 percent of those infected at birth developing chronic infection and 25 percent facing premature death from hepatitis-related illnesses.
The hepatitis B vaccine is both effective and well-tolerated, backed by decades of global safety data. The WCHA argues that offering it to all parents at birth remains essential for protecting the most vulnerable population.
The WCHA itself was formed in response to growing concerns regarding clarity and scientific integrity within federal public health agencies. The alliance aims to ensure that public health recommendations are firmly rooted in science, effectiveness, and safety, particularly in light of recent changes in CDC leadership and the perceived compromise of key advisory panels.
The organization has established a charter outlining its shared principles and scope of work, uniting California, Oregon, Washington, and Hawai’i in a commitment to upholding effective public health strategies. Key goals include providing access to credible data, fostering trust in public health initiatives, and developing evidence-based recommendations.
The WCHA’s shared principles prioritize health as a right, emphasize science and integrity, champion transparency
